EDGAR Filing Documents for 0001144204-15-021889

Form 8-K - Current report:

SEC Accession No. 0001144204-15-021889

Filing Date

2015-04-09

Accepted

2015-04-08 19:24:54

Documents

Period of Report

2015-04-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v406819_8k.htm	8-K	27426
2	EXHIBIT 10.1	v406819_ex10-1.htm	EX-10.1	87441
3	EXHIBIT 10.2	v406819_ex10-2.htm	EX-10.2	18897
4	EXHIBIT 10.3	v406819_ex10-3.htm	EX-10.3	18804
5	EXHIBIT 99.1	v406819_ex99-1.htm	EX-99.1	12705
6	GRAPHIC	image_002.jpg	GRAPHIC	3359
	Complete submission text file	0001144204-15-021889.txt		171487

Mailing Address 135 BEAVER ST WATHAM MA 02452

Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700

INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)